Table 1 Clinical characteristics of NSCLC patients treated with coaxial MWA and pre- and post-ablation CNB.
Variables | NSCLC patients(n = 33) | Variables | NSCLC patients(n = 33) |
|---|---|---|---|
Age(y) | 68.4 ± 12.0 | Radiological features |  |
Gender |  | Tumor diameter (cm) | 4.4 ± 2.2 |
 Male | 19(57.6%) | Location |  |
 Female | 14(42.4%) | Lower or middle lobe | 16(48.5%) |
Comorbidity | Â | Upper lobe | 17(51.5%) |
 Hypertension | 16(48.5%) | Emphysema | 12(36.4%) |
 CCVd | 12(36.4%) | Malignant pleural effusion | 4(12.1%) |
 DM | 5(15.2%) | Extrapulmonary metastases | 10(30.3%) |
Tumor stage | Â | Laboratory examinations | Â |
 I | 6(18.2%) | WBC(*109/L) | 6.5 ± 1.9 |
 II | 3(9.1%) | Hb(g/L) | 128.4 ± 18.6 |
 III | 7(21.2%) | PLT(*109/L) | 230.4 ± 68.2 |
 IV | 17(51.5%) | PT(s) | 11.5 ± 1.2 |
ECOG score |  | CEA(ng/ml) | 18.9 ± 42.5 |
 0 | 12(36.4%) | MWA-related factors |  |
 1 | 13(39.4%) | Ablation time between twice CNB (min) | 7.9 ± 5.5 |
 2 | 5(15.2%) | Power between twice CNB (W) |  |
 3 | 3(9.1%) | 30 | 18(54.5%) |
Treatment history | Â | 40 | 15(45.5%) |
 Surgery | 4(12.1%) | Maximum power (W) | 40.0 ± 7.9 |
 TKIs | 5(15.2%) | Total ablation time (min) | 11.4 ± 5.5 |